145 related articles for article (PubMed ID: 34973434)
1. Hysteroscopic Endometrial Resection in Women Treated With Tamoxifen for Breast Cancer Provides Definitive Diagnosis and Effective Long-Term Therapy.
Vilos GA; Alzawawi N; Oraif A; Lam JS; Badeghiesh A; Abu-Rafea B; Vilos AG
J Obstet Gynaecol Can; 2022 May; 44(5):517-520. PubMed ID: 34973434
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic Evaluation of Endometrial Changes in Breast Cancer Women with or without Hormone Therapies: Results from a Large Multicenter Cohort Study.
Chiofalo B; Mazzon I; Di Angelo Antonio S; Amadore D; Vizza E; Laganà AS; Vocaturo G; Calagna G; Favilli A; Palmara V; Maranto M; Vitale SG; Cucinella G; Granese R; Ghezzi F; Sperduti I; Triolo O
J Minim Invasive Gynecol; 2020; 27(4):832-839. PubMed ID: 31425735
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?
Garuti G; Grossi F; Cellani F; Centinaio G; Colonnelli M; Luerti M
Breast Cancer Res Treat; 2002 Apr; 72(3):245-53. PubMed ID: 12058966
[TBL] [Abstract][Full Text] [Related]
5. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
7. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy?
Elyashiv O; Sagiv R; Kerner R; Keidar R; Menczer J; Levy T
J Minim Invasive Gynecol; 2017; 24(7):1200-1203. PubMed ID: 28802955
[TBL] [Abstract][Full Text] [Related]
8. A randomized, prospective study of endometrial resection to prevent recurrent endometrial polyps in women with breast cancer receiving tamoxifen.
Goldenberg M; Nezhat C; Mashiach S; Seidman DS
J Am Assoc Gynecol Laparosc; 1999 Aug; 6(3):285-8. PubMed ID: 10459028
[TBL] [Abstract][Full Text] [Related]
9. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies.
Jeon J; Kim SE; Lee DY; Choi D
Breast Cancer Res Treat; 2020 Jan; 179(1):125-130. PubMed ID: 31541382
[TBL] [Abstract][Full Text] [Related]
12. Endometrial tubal metaplasia in a young puerperal woman after breast cancer.
Di Benedetto L; Giovanale V; Caserta D
Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678
[TBL] [Abstract][Full Text] [Related]
13. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
17. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-induced endometrial polyp. A case report and review of the literature.
Nomikos IN; Elemenoglou J; Papatheophanis J
Eur J Gynaecol Oncol; 1998; 19(5):476-8. PubMed ID: 9863916
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
20. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
